WELLS FARGO & COMPANY/MN - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,033,612
-31.4%
216,533
-49.4%
0.00%0.0%
Q2 2023$4,424,998
+13.1%
427,537
+0.9%
0.00%0.0%
Q1 2023$3,913,510
+13.4%
423,540
+8.8%
0.00%0.0%
Q4 2022$3,451,982
+5.5%
389,175
-1.0%
0.00%0.0%
Q3 2022$3,271,000
+2.2%
393,138
+0.6%
0.00%0.0%
Q2 2022$3,200,000
+44.7%
390,663
+53.8%
0.00%0.0%
Q1 2022$2,212,000
+36.1%
253,992
+48.6%
0.00%
Q4 2021$1,625,000
-28.1%
170,893
+27.1%
0.00%
Q3 2021$2,260,000
+643.4%
134,437
+575.0%
0.00%
Q2 2021$304,000
+266.3%
19,916
+368.3%
0.00%
Q1 2021$83,000
-86.5%
4,253
-87.5%
0.00%
Q4 2020$613,000
+12.1%
34,021
+19.9%
0.00%
Q3 2020$547,000
-36.3%
28,368
-13.7%
0.00%
Q2 2020$859,000
+294.0%
32,880
+169.2%
0.00%
Q1 2020$218,000
-37.9%
12,214
+16.2%
0.00%
Q4 2019$351,000
+50.6%
10,515
+7.2%
0.00%
Q3 2019$233,000
-22.3%
9,805
+17.6%
0.00%
Q2 2019$300,000
-54.1%
8,341
-45.1%
0.00%
Q4 2018$653,000
-24.0%
15,181
-16.5%
0.00%
Q3 2018$859,000
-8.5%
18,189
-3.6%
0.00%
Q2 2018$939,000
+1816.3%
18,871
+1806.2%
0.00%
Q1 2018$49,0009900.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders